HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,561-7,572 of 27,277
Drug study icon
CompletedACTRN12617000002381

Two different formulations of buprenorphine in healthy volunteers.

Official study title

An open label, two-­way crossover study to evaluate the absolute bioavailability of BnoX Trademark, a novel sublingual wafer formulation of buprenorphine, in healthy volunteers under fasted conditions.

This study has finished and is no longer accepting participants.

In Australia
AddictionInterventional studyAges 18–65
Countries
Australia
Sponsor
iX Biopharma Pty Ltd
Drug study icon
CompletedNCT00621777

Varenicline or placebo to prevent smoking relapse in schizophrenia or bipolarity

About this title

A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder

Read the official source — NCT00621777
Official study title

Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Bipolarity, SchizophreniaMedication studyAges 18–70
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00645320

Ziprasidone for psychosis after successful treatment in an earlier study

About this title

A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study

Read the official source — NCT00645320
Official study title

An Open Label, Extension Study To Assess The Efficacy And Tolerability Of Oral Ziprasidone In Patients Successfully Completing A Previous Study With Ziprasidone

This study has finished and is no longer accepting participants.

Multiple locations, including RIO de Janeiro RJ
SchizophreniaMedication studyAges 18–55
Countries
Brazil
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Other study type icon
CompletedNCT04132557

A Study on Suicide prevention, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Official study title

Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine, a Post-authorization Safety Study

This study has finished and is no longer accepting participants.

In Titusville
Suicidality, SchizophreniaObservational study
Countries
United States
Sponsor
Janssen Research & Development, LLC
Other study type icon
CompletedNCT01932398

A Study on the Inter-Hemispheric Alpha Ratio in Kids With ADHD (SHARK)

Official study title

Posterior Alpha Oscillations as an Index for the Attentional Bias in Children With Attentional Deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Nijmegen
ADHDObservational studyAges 84–95 months
Countries
Netherlands
Sponsor
Radboud University Medical Center

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.